Quidel Corporation is a leading manufacturer of diagnostic solutions at the point of care, delivering a continuum of rapid testing technologies that further improve the quality of health care throughout the globe. An innovator for over 40 years in the medical device industry, Quidel pioneered the first FDA-cleared point-of-care test for influenza in 1999 and was the first to market a rapid SARS-CoV-2 antigen test in the U.S. Under trusted brand names Sofia®, Solana®, Lyra®, Triage® and QuickVue®, Quidel's comprehensive product portfolio includes tests for a wide range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. With products made in America, Quidel's mission is to provide patients with immediate and frequent access to highly accurate, affordable testing for the good of families, communities and the world.
Company profile
Website
CEO
Douglas Bryant
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Diagnostic Hybrids, Inc. • Quidel Cardiovascular Inc. • Quidel Ireland Limited • Quidel China Ltd. ...
IRS number
942573850
Latest filings (excl ownership)
15-12G
Securities registration termination
6 Jun 22
25-NSE
Exchange delisting
27 May 22
SD
Conflict minerals disclosure
26 May 22
8-K
Submission of Matters to a Vote of Security Holders
16 May 22
425
Business combination disclosure
6 May 22
8-K
Other Events
6 May 22
425
Business combination disclosure
4 May 22
10-Q
2022 Q1
Quarterly report
4 May 22
425
Business combination disclosure
4 May 22
8-K
Quidel Reports First Quarter 2022 Financial Results
4 May 22
Transcripts
Earnings call transcript
2022 Q2
5 Aug 22
Earnings call transcript
2022 Q1
5 May 22
Earnings call transcript
2021 Q4
18 Feb 22
Earnings call transcript
2021 Q3
5 Nov 21
Earnings call transcript
2021 Q2
6 Aug 21
Earnings call transcript
2021 Q1
7 May 21
Earnings call transcript
2020 Q4
19 Feb 21
Earnings call transcript
2020 Q3
29 Oct 20
Earnings call transcript
2020 Q2
31 Jul 20
Earnings call transcript
2020 Q1
6 May 20
Latest ownership filings
Financial summary
| Quarter (USD) | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
Institutional ownership, Q2 2022
16.0% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 9 |
| Opened positions | 1 |
| Closed positions | 344 |
| Increased positions | 2 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 545.95 mm |
| Total shares | 6.22 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Alger Associates | 2.22 mm | $0.00 |
| Senvest Management | 2.16 mm | $218.27 mm |
| Larry N Feinberg | 1.81 mm | $325.12 mm |
| Meeder Asset Management | 11.75 k | $1.14 mm |
| Aurora Investment Counsel | 11.54 k | $1.30 mm |
| Captrust Financial Advisors | 904.00 | $102.00 k |
| Thrivent Trust Co of Tennessee | 69.00 | $8.00 k |
| Glassman Wealth Services | 62.00 | $6.00 k |
| IFP Advisors | 40.00 | $3.00 k |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 27 May 22 | Bryant Douglas C | Common Stock | Sale back to company | Dispose D | No | No | 0 | 505,926 | 0.00 | 0 |
| 27 May 22 | Bryant Douglas C | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 794 | 0.00 | 0 |
| 27 May 22 | Bryant Douglas C | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 2,646 | 0.00 | 0 |
| 27 May 22 | Bryant Douglas C | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 24,187 | 0.00 | 0 |
| 27 May 22 | Bryant Douglas C | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 27,043 | 0.00 | 0 |
| 27 May 22 | Bryant Douglas C | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 3,347 | 0.00 | 0 |
| 27 May 22 | Bryant Douglas C | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 2,921 | 0.00 | 0 |
| 27 May 22 | Bryant Douglas C | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 7,590 | 0.00 | 0 |
| 27 May 22 | Bryant Douglas C | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 2,192 | 0.00 | 0 |
| 27 May 22 | Bryant Douglas C | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 7,309 | 0.00 | 0 |